Australia is gain access to a groundbreaking medication for weight issues: Retatrutide. This new dual molecule – targeting on both GLP-1 and GIP receptors – demonstrates remarkable outcomes in international research, pointing to considerable reductions in weight. While availability remains with Australian regulators, many people battling being